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Viruses have developed a wide range of strategies to escape from
the host cells in which they replicate. For egress some archaeal
viruses use a pyramidal structure with sevenfold rotational symme-
try. Virus-associated pyramids (VAPs) assemble in the host cell
membrane from the virus-encoded protein PVAP and open at the
end of the infection cycle. We characterize this unusual supramolec-
ular assembly using a combination of genetic, biochemical, and
electron microscopic techniques. By whole-cell electron cryotomog-
raphy, we monitored morphological changes in virus-infected host
cells. Subtomogram averaging reveals the VAP structure. By heter-
ologous expression of PVAP in cells from all three domains of life,
we demonstrate that the protein integrates indiscriminately into
virtually any biological membrane, where it forms sevenfold pyr-
amids. We identify the protein domains essential for VAP formation
in PVAP truncation mutants by their ability to remodel the cell
membrane. Self-assembly of PVAP into pyramids requires at least
two different, in-plane and out-of-plane, protein interactions. Our
findings allow us to propose a model describing how PVAP arranges
to form sevenfold pyramids and suggest how this small, robust
protein may be used as a general membrane-remodeling system.
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Release of virus particles from infected cells is the last essentialstep of the viral replication cycle. In the course of this process,
virions face the challenging task of crossing the cell envelope.
Viruses have developed an arsenal of diverse strategies to overcome
this problem. Most bacterial viruses are lytic and induce lysis of the
infected cell with help of the holin-endolysin system (1), whereas
others disrupt the host cell envelope via inhibition of the murein
biosynthesis pathway (2). The morphological and genomic proper-
ties of archaeal viruses (3) suggested that their egress from host cells
may have unusual traits that are different from those of bacterial
viruses. Indeed, althoughmost archaeal viruses exit cellswithout lysis,
some, in particular the Sulfolobus islandicus rod-shaped virus 2
(SIRV2) and Sulfolobus turreted icosahedral virus (STIV), are lytic
and exploit a special mechanism of virion egress (4–8). During the
infection cycle of these viruses, pyramidal protrusions with sevenfold
rotational symmetry form in the host cell membrane. As the final
step of the infection cycle the virus-associated pyramids (VAPs)
open outwards along the seams of their seven facets, creating
∼100-nm apertures through which the newly formed virions es-
cape from the host cell (4, 7). VAPs consist of multiple copies
of an ∼10-kDa virus-encoded protein, which we term “PVAP”
(Protein forming Virus-Associated Pyramids/SIRV2_P98) (7–9).
Surprisingly, PVAP assembles into membrane pyramids even
when expressed heterologously in archaeal and bacterial expres-
sion systems, demonstrating that no other viral proteins are re-
quired for VAP formation (7). The mechanism by which VAPs
self-assembles in the membrane remains unknown.
In the present study we used electron cryotomography to in-
vestigate morphological features of SIRV2 replication and the
formation of VAPs at different time points after infection. By
subtomogram averaging, we determined a 3D map of the VAP.
This map, in combination with secondary structure predictions of
PVAP and the expression of wild-type (WT) PVAP or a variety of
truncation mutants in archaeal, bacterial and eukaryotic cells
allows us to propose a model showing how PVAP arranges to
form the sevenfold pyramids. These insights are fundamental for
understanding how this mechanism can be exploited as a univer-
sal tool to engineer the formation and controlled opening of large
pores in biological or artificial lipid bilayers.
Results
SIRV2 Induces Morphological Changes in the Host Cell. We analyzed
morphological changes in S. islandicus during SIRV2 infection
and the time points of VAP formation and opening by whole-cell
electron cryotomography at 0.5, 3, 6, and 12 h post infection (h.p.i.).
This strategy allowed us to monitor morphological changes at
high resolution and to compare these results with previous
results obtained by thin-sectioning of chemically fixed cells
during the final stages of SIRV2 infection (4). Up to 3 h.p.i.
infected cells were indistinguishable from uninfected control
cells, and no virions were visible in the cytoplasm (Fig. 1A).
This finding is in accordance with a previous study, in which
we have observed infection of S. islandicus by SIRV2 directly
in the electron microscope and suggests that SIRV2 does not
enter the cell as an intact virus particle (10). Electron-dense
Significance
The Sulfolobus islandicus rod-shaped virus 2 (SIRV2) has de-
veloped unique mechanisms to penetrate the plasma mem-
brane and S-layer of its host Sulfolobus islandicus in order to
leave the cell after replication. SIRV2 encodes the 10-kDa pro-
tein PVAP, which assembles into sevenfold symmetric virus-
associated pyramids (VAPs) in the host cell plasma membrane.
Toward the end of the viral replication cycle, these VAPs open
to form pores through the plasma membrane and S-layer,
allowing viral egress. Here we show that PVAP inserts spon-
taneously and forms VAPs in any kind of biological membrane.
By electron cryotomography we have obtained a 3D map of the
VAP and present a model describing the assembly of PVAP into
VAPs. Our findings open new avenues for a large variety of
biotechnological applications.
Author contributions: S.-V.A., W.K., and D.P. designed research; B.D., T.E.F.Q., M.S., D.J.M.,
J.R., Ö.Y., S.H., and C.S. performed research; W.K. and D.P. contributed new reagents/
analytic tools; B.D., T.E.F.Q., Ö.Y., P.F., S.-V.A., W.K., and D.P. analyzed data; and B.D.,
T.E.F.Q., W.K., and D.P. wrote the paper.
The authors declare no conflict of interest.
This article is a PNAS Direct Submission.
Freely available online through the PNAS open access option.
Data deposition: The map reported in this paper has been deposited in the Electron
Microscopy Data Bank, www.emdatabank.org (accession no. 5844).
1B.D. and T.E.F.Q. contributed equally to this work.
2To whom correspondence may be addressed. E-mail: werner.kuehlbrandt@biophys.mpg.
de or david.prangishvili@pasteur.fr.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1319245111/-/DCSupplemental.









globules (∼100 nm), similar to those reported for Sulfolobus
solfataricus cells (11), were the only conspicuous features in
the cytoplasm of controls and infected cells (Fig. 1A),. How-
ever, each cell, infected or not, contained one or a few of these
globules, which therefore are unrelated to virus replication. Their
size and density above the cytoplasmic background indicates that
they may be storage granules (12).
At 3–6 h.p.i., about half way through the infection cycle, newly
assembled virions became visible in the cytoplasm. as described
earlier (4). They were organized in up to three bundles per cell,
each consisting of roughly 50 rod-shaped particles (Fig. 1B).
Starting at 3 h.p.i., VAPs of various size formed in the plasma
membrane of the host cells, and most of these VAPS had pen-
etrated the S-layer (Figs. 1B and 2 A–D). Each cell contained on
average about 10 VAPs. The height of the VAPs (measured from
the membrane to the tip of the pyramid) ranged from ∼20–150
nm. At an early stage of formation the VAPs in the plasma
membrane had not yet punctured the S-layer of the host cell
(Fig. S1), but they already had the distinct features of hollow
heptagonal pyramids, corroborating the earlier assumption that
VAPs grow from the base by gradual expansion of their tri-
angular facets (7). Very occasionally, VAPs contained a spherical
storage granule (Fig. 2C). These granules likely correspond to
the previously described intrapyramidal bodies (IPB) in STIV-
induced VAPs (11). Analysis of cells at distinct time points post
infection showed that at 6 h.p.i. a number of VAPs had opened.
The fraction of open VAPs increased until at 12 h.p.i. all VAPs
had unfolded like the petals of a flower (Figs. 1C and 2 E–H).
The VAPs appeared to open as the pyramidal structures broke
along the seams of the triangular pyramid faces (Fig. 2F). The
VAP facets curved outwards with counterclockwise handedness
when viewed from the cell exterior (Fig. 2F), as suggested by
electron micrographs of isolated VAPs (7). As the VAPs opened,
the virion bundles disintegrated, and individual virions diffused
into the medium through the open VAPs (Fig. 3).
VAP Structure. The shape of isolated VAPs has been investigated
previously by negative staining and electron microscopy (7). To gain
insight in the structure of VAPs in situ, closed or open VAPs were
imaged by whole-cell electron cryotomography (Fig. 4 A–C). The
triangular faces of all VAPs appeared to consist of two distinct
layers, irrespective of their conformation or stage of assembly. The
outer layer (∼4.5 ± 1 nm) was continuous with and indistinguishable
from the cell membrane. The inner layer had a thickness of ∼4.0 ±
1 nm (Fig. 4). The center-to-center distance between the two
layers was 10.0 ± 1 nm, leaving a 5.8 ± 1 nm gap of lower density.
At the base of each VAP, the inner layer extended up to 15 nm
beyond the outer layer into the cytoplasm. These observations sug-
gest that the inner layer consists of a protein sheet that is attached
and runs parallel to the cytoplasmic membrane surface (Fig. 4).
To verify that both layers of the VAP consist only of PVAP
protomers, we analyzed archaeal (Sulfolobus acidocaldarius) or
bacterial (Escherichia coli) PVAP expression mutants constructed
in a previous study (7). Whole-cell electron cryotomography of
transformed cells revealed the distinctive two layers in all VAPs
(Fig. 4C and Fig. S2), indicating that both layers consist solely of
PVAP (Fig. S3).
Subtomogram Averaging of VAPs. A 3D map of the VAP was
obtained by averaging 57 tomographic subvolumes of closed
VAPs in the membrane of PVAP-expressing E. coli cells. Sec-
tions through the averaged volume parallel to the membrane
showed clear sevenfold symmetry (Fig. S3), which was applied to
the final average to improve the signal-to-noise ratio further
(Fig. 4 D–K and Movie S1). The local resolution estimated by the
program ResMap (13) was between 36 and 58 Å, with a mean
resolution of ∼43Å (Fig. S4). Because VAPs come in different
sizes, only the upper parts of the pyramids, to a height of ∼62 nm
and an outer diameter of ∼96 nm, were used for averaging. At
the tip, the inner opening angle of the pyramid was ∼80° (Fig.
4D). As observed in the raw tomograms, the structure consisted
of two layers (Fig. 4 D, E, and I–K). The outer layer formed a
continuous envelope, consisting of seven triangular facets (Fig.
4 F–K). As seen from the outside, the facets had a perceptible
counterclockwise handedness (Fig. 4F), and each facet was
slightly convex toward the inside (Fig. 4 F, G, J, and K). The
angle at the tip of the triangular facets was 35°, in accordance with
previous measurements on isolated VAP fragments (7). Overall,
the entire structure had the appearance of a tent or teepee (Fig. 4
G). The inner, cytosolic layer of the pyramid consisted of seven
triangular sheets parallel to the membrane on the outside (Fig. 4
I–K). Cross-sections through the sevenfold averaged volume
revealed narrow connecting densities between the two layers of
the pyramid, suggesting that they are physically linked (Fig. 4K).
Membrane Remodeling by PVAP. In silico secondary structure
predictions (14) and hydrophobicity analysis (15) of PVAP sug-
gest that the protein consists of an N-terminal transmembrane
helix (residues 5–34), followed by three hydrophilic α-helices of
two to three turns each separated by short linker regions (Fig.
S5). The PSORT-server (16) indicated that PVAP does not
contain a presequence. This result is consistent with a previous
study of the N-terminal amino acid sequence of purified PVAP
of SIRV2 with Edman degradation, which did not indicate
a cleavable signal sequence (9). Thus, we assumed that the hy-
drophobicity of its predicted N-terminal transmembrane seg-
ment drives the spontaneous insertion of PVAP into the lipid
bilayer. To test this hypothesis, PVAP was expressed in the
Saccharomyces cerevisiae, a eukaryotic organism. Cells were
harvested 16 h after induction of PVAP expression and were
high-pressure frozen and freeze-substituted. In addition, sections
prepared by the Tokuyasu method (17) were immunolabeled with
antibodies raised against PVAP. All samples were analyzed by
transmission electron microscopy. Surprisingly, VAPs were found
Fig. 1. Morphological changes of S. islandicus during infection with SIRV2. Tomographic slices of typical archaeal cells at 0.5 (A), 3–6 (B), and 9 (C) h.p.i. with
SIRV2. Black arrowheads indicate closed VAPs; white arrowheads indicate open VAPs. (Scale bars, 500 nm.)
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in most, if not all, cellular membranes. In size and appearance,
the pyramids were indistinguishable from those that assembled in
E. coli after PVAP expression or in S. islandicus after SIRV2
infection. PVAP-specific antibodies labeled VAPs in the nu-
clear envelope, the endoplasmic reticulum, Golgi apparatus,
intracellular vesicles, and mitochondria (Fig. 5).
Role of PVAP Domains in VAP Assembly. To identify which parts of
the PVAP are required for VAP assembly, truncated mutants
lacking the last 10, 20, 30, 40, or 70 C-terminal residues
(ΔC10, ΔC20, ΔC30, ΔC40, or ΔC70, respectively) were con-
structed (Fig. 6). Electron microscopy analysis of E. coli cells
transfected with these constructs revealed VAPs only in case
of the ΔC10 mutant (Fig. 6).
In contrast, VAPs did not form after truncation of 20–70
C-terminal residues (PVAPΔC20, ΔC30, ΔC40, or ΔC70, Fig. 6)
corresponding to one to three C-terminal α-helical segments.
Instead, expression of these constructs resulted mostly in protein
aggregates. In addition, constructs lacking 20–40 C-terminal
residues caused the inner membrane of E. coli to form large
invaginations, suggesting that these variants still interact with
the membrane (Fig. 6B). The effect was most pronounced for
PVAPΔC20. In contrast, PVAPΔC70 did not produce any
membrane invaginations (Fig. 6B).
Expression of a PVAP construct lacking the predicted N-terminal
transmembrane helix (PVAPΔN30) likewise did not result in VAP
formation. There was no sign of any interaction with the membrane
(Fig. 6B), indicating that the N-terminal transmembrane domain is
indeed required for membrane insertion of PVAP protomers.
We asked if the PVAP transmembrane domain is essential for
VAP formation or could be replaced by any other transmembrane
domain. To characterize the role of the PVAP transmembrane
domain in VAP formation, we constructed a chimera by fusing
the E. coli flagellar regulator Flk, a gene encoding a single trans-
membrane helix inner membrane protein (18), to PVAPΔN30,
replacing the N-terminal transmembrane helix (residues 1–30) of
PVAP (18). After expression, this fusion construct (PVAPtmFlk)
was indeed inserted into the membrane, as judged by Western blot
analysis of cell fractions with SIRV2-PVAP antibody (Fig. S6).
However, there was no evidence of VAPs in these cells (Fig. 6B).
Taken together these findings indicate that the N-terminal do-
main is essential for membrane insertion of PVAP and for the in-
teraction between PVAP protomers, which results in the assembly
of a protein sheet on the inner membrane surface. The C-terminal
domain of PVAP (except the last 10 residues, which are predicted
to be disordered) is required for VAP formation. Without this
domain, the protein aggregates instead of forming VAPs.
PVAP Oligomers. To characterize the oligomerization of PVAP in
vitro, we fused a His-tag to the C terminus and expressed the
protein heterologously in E. coli. Isolated membranes were solu-
bilized with the detergent N-laurylsarcosine. PVAP was purified by
nickel affinity chromatography and size-exclusion chromatography.
The single peak in the gel filtration profile corresponds to a
molecular mass of ∼70 kDa (Fig. S7). SDS/PAGE analysis of
peak fractions shows discrete PVAP bands at ∼10, 20, 30, and
70 kDa (Fig. S7), indicating that in detergent solution PVAP
forms different oligomers, the largest of which is most likely a
heptamer. A PVAP heptamer also is suggested by gel filtration
chromatography.
Fig. 2. VAPs in closed and open conformation. Tomographic slice (A, C, E,
and G) and segmented, surface-rendered volumes (B, D, F, and H) of VAPs in
the membrane of SIRV2-infected S. islandicus cells. VAPs are either closed
(A–D) or open (E–H). The S-layer is purple, the cell membrane is blue, and
the VAP is yellow. (Scale bars, 200 nm.)
Fig. 3. SIRV2 virion egress. Rendered tomographic volume of a SIRV2-
infected S. islandicus cell, 12 h.p.i. SIRV2 virions (orange, brown, and purple)
are released through open VAPs (yellow) that create ∼100-nm apertures in
the plasma membrane and S-layer (green). Virions inside the cell are orange;
virions escaping from the cell are purple; virions outside the cell are brown.
Viral or host DNA is transparent blue. (Scale bar, 500 nm.)










The VAP, an archeoviral egress structure that takes the shape of
a large, sevenfold pyramid in the host membrane, is without
parallel in biology. It consists of multiple copies of PVAP, a 10-kDa
membrane protein, which forms VAPs in the membrane, evidently
without the need for any other cellular component.
How does the 10-kDa PVAP assemble to form sevenfold pyr-
amids in the membrane? To address this question, we investigated
the VAP structure itself by electron cryotomography and have
studied the membrane insertion and biochemical properties of
PVAP. We have demonstrated that PVAP forms VAPs in archaeal,
bacterial, and eukaryotic membranes, into which it inserts indis-
criminately, and that, with the exception of the last 10 C-terminal
residues, the entire length of the protein is required for VAP as-
sembly. Finally, we have shown that PVAP forms oligomers, most
likely heptamers, in detergent solution.
PVAP is a Universal Membrane Remodeling System. Sequence analysis
of PVAP suggested that the protein does not contain a signal se-
quence and thus most likely integrates spontaneously into the ar-
chaeal membrane. A similar mechanism of membrane insertion has
been found for tail-anchored (TA) proteins (19) and for bacterial
pore-forming toxins (bPTFs) (20). TA proteins are indigenous
proteins that contain a single C-terminal transmembrane segment.
They are inserted into their target membrane in a Sec-independent
but organelle-specific manner, occasionally aided by cytoplasmic
chaperones (19). Similar to PVAP, bPTFs are expressed as mono-
mers and insert into the target membrane, where they assemble into
pore-forming oligomers, either to kill other bacteria or, in the case
of pathogens, to lyse the host membrane and thus aid bacterial
proliferation (20).
Overexpression of PVAP in the archaeon S. acidocaldarius, the
bacterium E. coli, and the eukaryote S. cerevisiae resulted in the
formation of VAPs in the plasma membranes of all hosts. Even
more remarkably, VAPs were observed in virtually all cellular
membranes of the eukaryote S. cerevisiae, including the nuclear
envelope, the endoplasmic reticulum, the mitochondrial outer
membrane, and the plasma membrane. This observation demon-
strates that, in contrast to other known types of proteins that
integrate into membranes, PVAP is able to insert into practically
any biological lipid bilayer solely by virtue of its N-terminal
transmembrane segment. Once inserted into the bilayer, it forms
sevenfold pyramids, irrespective of fundamental differences in
lipid or protein composition of the target membrane. These
characteristics render PVAP a unique, universal membrane
remodeling tool.
Supramolecular Organization of VAPs. Whole-cell electron cry-
otomography and subtomogram averaging revealed that the VAPs
consist of two layers of roughly equal thickness in all endogenous
Fig. 4. VAP structure. Tomographic slices through
closed (A) and open (B) SIRV2-induced VAPs of S.
islandicus and VAPs formed after PVAP expression in
E. coli (C), indicating two layers. One layer is con-
tinuous with the cell membrane (black arrowheads),
and the other (white arrowheads) forms a sheet at
the cytoplasmic surface of the membrane. VAPs in
S. islandicus protrude through the S-layer (white
arrows). (D–K) A 3D map of VAP obtained by sub-
tomogram averaging, with sevenfold symmetry ap-
plied. Tomographic slice perpendicular to the pyramid
base (D) and successive tomographic slices parallel to
the base (E) show the two layers in the walls of the
pyramid. (F) Top view of the 3D map in solid repre-
sentation shows that the edges of the seven pyramidal
facets are slightly curved counterclockwise (dotted
lines). (G–K) Different orientations of the 3D map in
surface representation. Transparent mesh and golden
surface show different threshold levels. Black and
white arrowheads indicate the outer and inner layer,
respectively. Open arrowheads indicate connections
between inner and outer layers of the VAP. (Scale
bars, 200 nm in A–C, 50 nm in D and E.)
Fig. 5. VAP formation in S. cerevisiae. PVAP expression in S. cerevisiae causes VAP formation in various cellular membranes. (A and B) Immunolabeling of
thawed cryosections with anti-PVAP antibodies. (A) VAP in the endoplasmic reticulum. (B) VAPs in mitochondrial membranes (C) Freeze-substituted cell with
VAP in the nuclear envelope. The inset shows an enlarged VAP. CW, cell wall; M, mitochondrion; N, nucleus; P, plasma membrane. Arrows indicate VAPs.
(Scale bars, 200 nm.)
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and heterologous expression hosts. The outer layer was continuous
with the plasma membrane, whereas the inner layer formed a dis-
continuous sheet at the cytoplasmic membrane surface. Because
PVAP must insert with its N-terminal transmembrane segment into
the plasma membrane, the outer layer most likely consists of
multiple copies of this part of PVAP plus interspersed mem-
brane lipid. In turn, the cytoplasmic protein sheet must consist
of the tightly associated C-terminal domains of the protein. The
low-density region between the two layers then would account
for the linker region between the cytoplasmic domains and the
N-terminal transmembrane segments (Fig. 7A).
Recently it was suggested that the opening of STIV-induced
VAPs depends on polymerization of Endosomal Sorting Complexes
Required for Transport (ESCRT)-III homologs, resulting in the
stripping of VAPs from their cytoplasmic membrane (21). Our
observation that the outer layer of the double-layered VAP struc-
ture is continuous with the plasma membrane (Fig. 4) does not
support this model. Moreover, global analysis of host gene expres-
sion during the SIRV2 infection cycle documented that ESCRT-
III–like proteins were down-regulated in infected cells (22). Thus, it
is possible, although not very likely, that mechanisms of VAP
opening differ in SIRV2- and STIV-infected cells.
Our tomograms of closed and open VAPs throw some light on
the mechanism by which the pyramids open to facilitate viral
egress. The seven edges of the closed pyramid are slightly curved
in a right-handed fashion (Fig. 4F). In the open state, the edges
of the seven individual facets are curved in the same way (Fig.
4F). In the open VAP, each facet curls outwards (Fig. 4F). These
observations suggest that in the closed state the VAP structure is
under mechanical tension. This tension likely provides the en-
ergy required for VAP opening. Because the tip of the VAP
displays the point of strongest membrane curvature in the whole
assembly, it most likely serves as predetermined breaking point
at which the pyramid would begin to unfold along its seams.
VAP Assembly and Opening. We propose a model for VAP as-
sembly (Fig. 7). Upon synthesis in the cytosol, PVAP integrates
spontaneously into the cell membrane, depending solely on the
hydrophobicity of its N-terminal transmembrane helix segment.
In the membrane, tight interactions between PVAP protomers
result in the formation of protein sheets that consist of the ob-
served two layers. We propose that this interaction involves both
the N-terminal transmembrane helices and the C-terminal
hydrophilic PVAP domains, as indicated by the expression of
truncation constructs.
To assemble into a pyramid instead of a flat sheet, at least
two different kinds of interactions between PVAPs are neces-
sary, one in-plane interaction within the triangular facets and
one out-of-plane interaction at the edges of the pyramid. The
interaction at the edges is most likely weaker than the in-plane
interaction, so that the pyramids open along these lines. Be-
cause all VAPs observed in S. islandicus or in heterologous
systems grow to roughly the same size, the expansion of VAP
must be constrained in some way.
At present it is unknown whether the pyramids are built in
a one-by-one self-assembly process from individual PVAP pro-
tomers or whether, upon membrane insertion, the protomers
assemble into heptamers that then combine into pyramids in
a second stage of assembly. The prior formation of heptamers in
the membrane is suggested by the gel filtration experiments,
which show one homogenous peak of ∼70 kDa in detergent
solution. Given that detergent mimics the hydrophobic mem-
brane environment, it is likely that the same interactions that
give rise to the heptamer in a detergent micelle also would
Fig. 6. Expression of truncated variants of PVAP in E. coli. (A) Schematic
representation of WT PVAP and its truncated variants. PVAPΔC10, PVAPΔC20,
PVAPΔC30, PVAPΔC40 40, and PVAPΔC70, the truncated variants of PVAP
lacking the last 10, 20, 30, 40, or 70 C-terminal residues, respectively;
PVAPtmFlk, the PVAP variant in which the transmembrane segment was
replaced by that of the E. coli membrane protein Flk; and ΔN30, where the
transmembrane segment of PVAP was deleted entirely. (B) Electron micro-
graphs of thin sections through E. coli cells expressing PVAP constructs as
in A. VAPs (open arrows) and invagination of the membrane (black arrow)
are shown. (Scale bars, 200 nm; scale bar in Inset, 100 nm.)
Fig. 7. Model of VAP assembly. (A) Predicted secondary structure of PVAP
with an N-terminal transmembrane helix and three short C-terminal α-helices.
(B) Schematic top view of the VAP with its seven facets shown in different
colors. Strong interactions between individual PVAP protomers stabilize the
integrity of each facet, whereas weak interactions at the seams (white
dashed lines) between two neighboring facets form predetermined break
points. The black dashed line indicates the cross-section through the VAP in
C. (C) PVAP protomers (green) insert spontaneously into the plasma mem-
brane (blue), with the short C-terminal helices exposed to the cytoplasm.
Close contacts between PVAP molecules in each facet (aqua and orange
outline) exclude S-layer proteins (gray) and combine into a protein sheet
below the plasma membrane. The addition of PVAP units at the base
pushes the pyramid outwards.









promote the formation of heptamers in the membrane, which
thus may be the building blocks of the pyramids.
VAP opening presumably involves a host or virus-specific factor,
because the pyramids open only in virus-infected Sulfolobus cells
but remain closed in PVAP-expressing bacteria and yeast. Once
the mechanism that triggers VAP opening is elucidated, this sys-
tem could be used to introduce ∼100-nm apertures in any lipid
bilayer. VAPs then might be used for targeted drug delivery, re-
leasing compounds from liposomes upon a specific signal. In ad-
dition, the PVAP transmembrane domain has the ability to insert
into all types of biological membranes and therefore may be fused
to proteins that otherwise cannot be reconstituted into lipid
bilayers. This system thus has interesting potential applications in
basic research, biotechnology, and therapy.
Materials and Methods
Virus and Host Strains. S. islandicus LAL 14/1 cells were grown, synchronized,
and infected with SIRV2 as described previously (7) and in SI Materials
and Methods.
Plasmid Constructs and Transformation of S. acidocaldarius. SIRV2_ORF98
(National Center for Biotechnology Information RefSeq ID: NP_666583) was
amplified from SIRV2 genomic DNA and cloned into the pSVA1450 plasmid
behind an araS promoter, which yielded pTQ26. pTQ26 was transformed to
S. acidocaldarius M31 as described in SI Materials and Methods.
Plasmid Constructs and Transformation of E. coli. SIRV2_ORF98 was amplified
from SIRV2 genomic DNAwith different primers resulting in 3′-truncated PCR
products of 267, 237, 207, 177, and 87 bp. A 5′ truncation of ORF98 was
created by amplification of a 216-bp product starting at position 81. The
same sequence was fused with the 75-bp transmembrane segment of the
E. coli Flk gene as described in SI Materials and Methods. All PVAP gene
mutants were cloned into the T7 promoter-driven expression vector pSA4.
Expression was induced with isopropyl β-D-1-thiogalactopyranoside (IPTG).
Analysis of PVAP-expressing cultures by high-pressure freezing, freeze-sub-
stitution, and Western blotting was performed as described in refs. 7 and 9.
Plasmid Constructs and Transformation of S. cerevisiae. SIRV2_ORF98 was
amplified from SIRV2 genomic DNA and cloned in the expression vector
pCM190. S. cerevisiae was transformed with this plasmid. A preculture was
grown in selective medium as described in SI Materials and Methods. After 1 d,
cells were diluted 1/1,000 in medium without doxycycline.
Immunoelectron Microscopy. Yeast cells were fixed, washed, and pelleted in
gelatin, and the gelatin pellet was solidified on ice and cut into small blocks as
described in SI Materials and Methods. These blocks were infiltrated with 2.3 M
sucrose, mounted on aluminum pins, and frozen in liquid nitrogen. Thin sections
were cut and picked up in a 1:1 mixture of 2.3 M sucrose and 2% (wt/vol)
methylcellulose. Labeling for PVAP was done as described previously (7).
High-Pressure Freezing and Freeze-Substitution. E. coli cells were taken up in
cellulose capillary tubes, and S. cerevisiae cultures were concentrated by
filtration. Samples were high-pressure frozen, and freeze-substitution was
performed in anhydrous acetone containing 2% (wt/vol) osmium tetroxide.
Afterwards the samples were washed with dry acetone and embedded
stepwise in EPON (Agar 100 resin; Agar Scientific). After heat polymerization
thin sections were cut, collected on 200-mesh Formvar-coated copper grids,
and poststained as described in SI Materials and Methods. Images were
recorded with a JEOL 1010 electron microscope equipped with an Olympus
Keen View camera.
Whole-Cell Cryotomography. S. islandicus cells were harvested, concentrated
by low-speed centrifugation, and plunge-frozen. E. coli cells overexpressing
PVAP were harvested under the same conditions, washed once in 50 mM
Tris, 300 mM NaCl, pH7, and plunge-frozen in the same buffer. Before
freezing, suspensions were mixed with an equal volume of 10-nm colloidal
protein-A gold suspension. Tomograms were recorded with a Polara G2
Tecnai field emission transmission electron microscope equipped with
a Gatan Tridiem energy filter and a 2 × 2 k CCD camera. Tomographic tilt
series of zero-loss filtered images were recorded, and tomograms recon-
structed as described in SI Materials and Methods.
Subtomogram Averaging. For subtomogram averaging of VAPs, 57 pyramid
volumes were cut out from a single tomogram of an E. coli cell over-
expressing PVAP and were aligned, and averaged applying sevenfold rota-
tional symmetry using the PEET software as described in SI Materials and
Methods. The resolution of the map was estimated using the ResMap soft-
ware (13).
PVAP Purification. A codon-optimized SIRV_ORF98 gene was synthetized and
inserted in the plasmid pET26b. E. coli BL21DE3/Rosetta/pLysS cells were
transformed with this plasmid. Protein expression was induced with 1 mM
IPTG. After 2 h, cells were pelleted, resuspended in lysis buffer, and dis-
rupted with a Microfluidizer. The membrane fraction was pelleted by cen-
trifugation and diluted in 50 mM Tris (pH 7.0), 300 mM NaCl to a protein
concentration of 5 mg/mL. Then 1.5% (vol/vol) N-laurylsarcosine was added.
After high-speed centrifugation the supernatant was loaded onto a Ni-NTA
column followed by several washing steps. The protein was eluted in buffer
containing 500 mM imidazole and concentrated using Amicon spin columns
with a 30-kDa cutoff before loading onto a gel filtration column, as de-
scribed in more detail in SI Materials and Methods.
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